Research location
Klerksdorp
South Africa
Advertisement
Research activity in Klerksdorp
South AfricaCureCurrent currently publishes aggregate city-level research activity for this location: 21 trials and 21 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Klerksdorp
21 linked trials · page 1 of 1Evaluating the Safety and Immunogenicity of MTBVACNCT05947890 · 2024-01-30 · 1 site observation
RECRUITING
Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)NCT05580666 · 2023-05-08 · 1 site observation
RECRUITING
Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy ParticipantsNCT05959707 · 2024-08-14 · 1 site observation
SUSPENDED
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and AdultsNCT06062238 · 2024-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years OldNCT04337450 · 2022-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of ConcernNCT05168813 · 2021-12-01 · 1 site observation
COMPLETED
Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.NCT05182125 · 2021-11-25 · 1 site observation
COMPLETED
Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV InfectionNCT04994509 · 2021-08-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess the Efficacy of a Heterologous Prime/Boost Vaccine Regimen of Ad26.Mos4.HIV and Aluminum Phosphate-Adjuvanted Clade C gp140 in Preventing Human Immunodeficiency Virus (HIV) -1 Infection in Women in Sub-Saharan AfricaNCT03060629 · 2017-11-03 · 1 site observation
TERMINATED
ODYSSEY (PENTA 20)NCT02259127 · 2016-09-20 · 1 site observation
COMPLETED
The Evidence for Contraceptive Options and HIV Outcomes TrialNCT02550067 · 2015-12-14 · 1 site observation
COMPLETED
A Safety and Immune Response Study of 2 Experimental HIV VaccinesNCT02404311 · 2015-02-02 · 1 site observation
COMPLETED
Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionNCT02178592 · 2015-01-23 · 1 site observation
COMPLETED
Safety of and Immune Response to Vaccination With 2 Experimental HIV Vaccines in Healthy AdultsNCT02109354 · 2013-06-18 · 1 site observation
COMPLETED
Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected AdultsNCT01215149 · 2010-10-01 · 1 site observation
COMPLETED
Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in WomenNCT00705679 · 2009-08-01 · 1 site observation
COMPLETED
Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African AdultsNCT00413725 · 2007-01-01 · 1 site observation
COMPLETED
Acute HIV Infection Observational StudyNCT00296660 · 2006-06-01 · 1 site observation
COMPLETED
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard ChemotherapyNCT00338286 · 2006-03-02 · 1 site observation
COMPLETED
HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult ParticipantsNCT00125970 · 2005-09-01 · 1 site observation
COMPLETED
Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa StudyNCT00229697 · 2003-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.